Literature DB >> 2852418

Chromatin structure of hormone-responsive Moloney murine leukemia virus proviruses that contain sequences from mouse mammary tumor virus.

T Thompson1, H Fan.   

Abstract

The chromatin structure of chimeric Moloney murine leukemia viruses (M-MuLVs) containing a glucocorticoid response element (GRE) from mouse mammary tumor virus (MMTV) inserted into the long terminal repeat (LTR) was investigated. Nuclear run-on assays indicated that transcription from the chimeric proviruses was induced 2- to 4-fold by dexamethasone. The wild-type M-MuLV 5' LTR contained a DNase I hypersensitive (HS) site at the TATA sequences, as well as four sites in the enhancer region. The chimeric LTRs contained these sites, as well as three additional sites in the MMTV sequences. Two of the MMTV sites were present in the absence of hormone, while one was hormone-induced. In addition, internal MMTV sequences appeared protected from DNase I digestion in the absence of hormone, suggesting bound protein. Hormone treatment resulted in loss of the DNase I protection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852418     DOI: 10.1007/bf00569738

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  25 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Glucocorticoids and chromosomal position modulate murine mammary tumor virus transcription by affecting efficiency of promoter utilization.

Authors:  D S Ucker; G L Firestone; K R Yamamoto
Journal:  Mol Cell Biol       Date:  1983-04       Impact factor: 4.272

3.  Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.

Authors:  L A Laimins; P Gruss; R Pozzatti; G Khoury
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

4.  Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer.

Authors:  D DeFranco; K R Yamamoto
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

5.  Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties.

Authors:  H Ponta; N Kennedy; P Skroch; N E Hynes; B Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

6.  Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.

Authors:  J Overhauser; H Fan
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

7.  Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus.

Authors:  R Miksicek; A Heber; W Schmid; U Danesch; G Posseckert; M Beato; G Schütz
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

8.  Molecular cloning of unintegrated and a portion of integrated moloney murine leukemia viral DNA in bacteriophage lambda.

Authors:  A J Berns; M H Lai; R A Bosselman; M A McKennett; L T Bacheler; H Fan; E C Maandag; H V van der Putten; I M Verma
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

9.  Low-multiplicity infection of Moloney murine leukemia virus in mouse cells: effect on number of viral DNA copies and virus production in producer cells.

Authors:  H Fan; R Jaenisch; P MacIsaac
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

10.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

View more
  1 in total

1.  Chromatin structure of recombinant Moloney murine leukemia virus proviral DNAs that contain tax-responsive sequences from human T-cell lymphotropic virus type II in the presence and absence of tax.

Authors:  H Kitado; H Fan
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.